Articles

“Newer” Ovarian Cancer Genes, Option of Risk-Reducing Salpingo-Oophorectomy

The ability to analyze multiple genes at the same time has led to the estimate that 20% to 25% of women with ovarian cancer have an inherited mutation in a cancer-predisposing gene. Read More ›

Diagnostic Imaging Agent FDA Approved for Rare Neuroendocrine Tumors

FDA Updates

TON July 2016 Vol 9 No 4

Diagnostic Imaging Agent FDA Approved for Rare Neuroendocrine Tumors

Diagnostic Blood Test FDA Approved for NSCLC Gene Mutation

Axumin FDA Approved for Recurrent Prostate Cancer

From the Editor

By Beth Faiman, PhD, APRN-BC, AOCN

From the Editor

TON July 2016 Vol 9 No 4

We hope you enjoy this issue, and sincerely look forward to receiving your feedback. Read More ›

Molecular Profiling Is Vital in Patients with Metastatic Cancer

By Meg Barbor, MPH

Conference Correspondent

TON July 2016 Vol 9 No 4

Physicians need to advocate for molecular profiling, according to Howard "Skip" Burris III, MD. Read More ›

Electronic “Facility Board” Provides Easy Look at Patient Status

By Caroline Helwick

Conference Correspondent

TON July 2016 Vol 9 No 4

An electronic "facility board" situated on a wall in the nurses station of a medical/surgical unit led to more clinical interventions for abnormal vital signs, a reduction in falls among high-risk patients, and more ordering of specialty beds, according to nurses from Cancer Treatment Centers of America (CTCA) at Eastern Regional Medical Center in Philadelphia, PA. Read More ›

Opioid Prescriptions for Pain Management: Safe Patient, Prescriber, Community

By Wayne Kuznar

Conference Correspondent

TON July 2016 Vol 9 No 4

Achieving balance in the appropriate use of opioids to treat cancer pain requires skill and compassion. Read More ›

Palliative Care Specialists Want More Involvement

By Audrey Andrews

Conference Correspondent

TON July 2016 Vol 9 No 4

When patients hear the phrase palliative care, they sometimes feel their oncology team is "giving up on them," according to a survey of attendees at the National Comprehensive Cancer Network (NCCN) 21st Annual Conference. Read More ›

The Benefits of Triage and the COME HOME Model

By Meg Barbor, MPH

Conference Correspondent

TON July 2016 Vol 9 No 4

At the heart of the oncology medical home is triage, according to Barbara McAneny, MD, Chief Executive Officer of New Mexico Cancer Center as well as Innovative Oncology Business Solutions (IOBS), where she also serves as chief medical officer. Read More ›

SWOT Meets Wound Care Needs

By Caroline Helwick

Conference Correspondent

TON July 2016 Vol 9 No 4

The creation of a dedicated wound ostomy care (WOC) team resulted in an almost complete elimination of pressure ulcers in a 74-bed hospital, according to nurses who created it and described the program at the Oncology Nursing Society 41st Annual Congress Read More ›

Significant Roadblocks to Oncology Appointments at NCI Cancer Centers

By Meg Barbor, MPH

Conference Correspondent

TON July 2016 Vol 9 No 4

Newly diagnosed cancer patients face fear and uncertainty regarding their prognosis. Read More ›